www.oltca.com LONG TERM CARE TODAY 19 demonstrated its ability to clearly document wound progression over time, creating a clear and comprehensive record for both clinicians and administrators. Saving time was another outcome. By automatically measuring wounds and tracking changes over time, as well as consolidating assessments, treatment recommendations and images into a single platform, Skinopathy Wounds demonstrated its ability to eliminate manual tasks that traditionally consume nurses' time. “I found it helpful that the AI makes recommendations while still integrating the clinician’s own skills and knowledge,” Muhammed says. "Seeing clinicians realize they can spend more time doing what they want to do, helping patients, has been the biggest eye-opener for me," Loo adds. In addition to expediting the assessment process – “a big deal for the nurses working on the floor,” Muhammed says – the team also found Skinopathy Wounds effective in identifying tissue composition and recommending appropriate dressings based on products already available in the home. It also allowed nurses to refer cases directly to a physician or wound care specialist from within the app. At a broader level, the evaluation demonstrated how AI technologies could be especially valuable in providing evidence-based guidance to less experienced nurses when specialized wound care expertise isn't immediately available. Perhaps the most significant outcome of the evaluation was improved consistency, Killing says. By accounting for factors such as skin tone, lighting conditions, and wound composition, Skinopathy Wounds helped clinicians make more consistent assessments while recommending appropriate dressings. That consistency has important clinical implications. At peopleCare, for example, Killing explains that wounds that deteriorate over two consecutive assessments are referred to a specialist. Inconsistent assessments can delay those referrals. The above observations were reflected in the evaluation findings. Documentation completion reached 98.6%, while the average wound assessment took just 6.5 minutes, compared with the typical 10 to 15 minutes. During the evaluation, one in four difficult-to-heal wounds healed, while more than one-third were identified early for enhanced care. Together, the findings point to the potential for AI to support more timely, consistent wound care in long-term care settings. Refining the technology One of peopleCare's goals for the initiative was to help Skinopathy better understand the realities of wound care in long-term care, so that the company could create a platform built around the needs of Ontario's long-term care nurses, rather than one adapted to them after the fact. Dr. Rakesh Joshi, a Lead Scientist at Skinopathy, worked across the two organizations to do just that. "We learned that technology is only going to be adopted if it fits into nurses' day-to-day workflow," he says. That lesson has shaped how Skinopathy is now deploying the platform. While the core AI remains the same, Joshi says the company is customizing the technology to reflect each home's existing workflows, dressing supplies, policies and care protocols. "The core technology is going to be the same, but we're going to tailor to each specific long- term care home. We realized that if you don't do that, nurses will not get the full benefit of your system,” he says. Building on the experience With the peopleCare evaluation complete, Skinopathy is currently focused on expanding access, continuing research and helping more long-term care residents in Ontario. For co-founder Dr. Allan Wu, OLTCA’s Together We Care conference marked a turning point in that regard. "Together We Care was a phenomenal opportunity for us to actually meet the community," he says, noting those connections are now helping launch the company's commercialization efforts. At the same time, the company is partnering with the National Research Council on a two- year research initiative to further enhance the technology and expand its use across the continuum of care, from home care and outpatient clinics to long-term care. While Skinopathy looks ahead to the next phase of its own work, peopleCare is reflecting on what was learned. "Not every evaluation project leads directly to implementation, and that's OK," says Killing. "The research matters. We set out to answer important questions about how AI could support wound care in long-term care, and we answered nearly all of them. Along the way, we strengthened our own wound care program and generated evidence that can help inform future innovation across the sector. Those outcomes continue to have value, regardless of where the technology goes next." LTCT WOUND CARE
View this content as a flipbook by clicking here.